ArticleNature communications2026
In-plane molecular cord bridging as a method for boosting MXene fiber strength and toughness.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
MXenes enable high-performance fibers with strength, toughness, and conductivity, yet weak edge-to-edge interactions between nanosheets remain a critical challenge. Inspired by the cord-bound architecture of lamellar armor, we use molecular cords of carboxymethyl cellulose-wrapped single-walled carbon nanotubes to bridge adjacent MXene nanosheets via ionic coordination. Through mild and continuous wet-spinning, crosslinking, and hot-pressing, we fabricate MXene fibers containing only 0.12 wt% of the molecular cords that deliver enhanced mechanical properties: a tensile strength of 1.48 ± 0.06 GPa (peak: 1.55 GPa), ductility of 17.7 ± 0.8%, and toughness of 131.0 ± 8.7 MJ m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.